Comprehensive Disease Management Program in Chronic Obstructive Pulmonary Disease (COPD) Patients in the Community
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Other: Disease managementOther: Best care
- Registration Number
- NCT00982384
- Lead Sponsor
- Sheba Medical Center
- Brief Summary
The purpose of this study is to determine whether comprehensive disease management program combined with best care recommended in clinical guidelines, is more effective than best care alone in patients with advanced chronic obstructive pulmonary disease (COPD).
- Detailed Description
The study objective is to evaluate the effectiveness of a comprehensive program among patients with advanced COPD, implemented by a multi-disciplinary team. The program consists of best care recommended in clinical guidelines, combined with disease management, compared to best care only.
The program will include designated COPD centers operated by multi-disciplinary teams (pulmonologists, nurse practitioners, physiotherapists, social workers and dietitians). Disease management will be provided in these centers by qualified designated nurses.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1202
- Age 40 years or older
- Advanced COPD
- Permanent tracheostomy
- Heart failure with significant left-ventricular dysfunction
- Severe other chronic disease
- Significant cognitive impairment, Drug or alcohol abuse, inability to cooperate
- No telephone or permanent address
- Bedridden
- Refusal to use telemonitoring equipment
- Participation in another clinical trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Disease management Disease management Comprehensive disease management in addition to best care according to clinical guidelines for COPD patients Best care Best care Best care according to clinical guidelines for COPD patients
- Primary Outcome Measures
Name Time Method Hospital admission for acute exacerbation of COPD or all-cause mortality Within 2 to 5 years after randomization
- Secondary Outcome Measures
Name Time Method Depression Within 2 to 5 years after randomization Functional capacity Within 2 to 5 years after randomization Spirometry parameters Within 2 to 5 years after randomization Total days of hospitalization for acute exacerbations of COPD Within 2 to 5 years after randomization Total number of acute exacerbations of COPD Within 2 to 5 years after randomization Quality of life Within 2 to 5 years after randomization
Trial Locations
- Locations (2)
Bat-Yam COPD Center
🇮🇱Bat-Yam, Israel
COPD Center, Hadera
🇮🇱Hadera, Israel